Back to Screener

Industrials

SurgLine International, Inc.(SGLN)

Live Price

Offline

$0.0001

+0.00% today

1Y Change

+0.00%

Window

Jun 23, 2025 โ†’ Jun 15, 2026

Market Cap
โ€”
Revenue Growth
0.0%
EPS Growth
+95.0%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 23, 2025 โ†’ Jun 15, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

SurgLine International, Inc. (SGLN) is a Industrials stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ†’ Jun 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +95.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +95.0%, free cash flow -123.8% with operating margin -1832.4% and ROIC 176.9%. Valuation sits in the middle of the pack at price/sales 5.0. Stock Foundry combines SGLN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +3.6% peer median

Operating Margin

Below sector median

-1832.4% vs +16.9% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

The setup is mixed rather than one-directional

Revenue is 0.0% and EPS is +95.0%, while operating margin sits near -1832.4%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SGLN

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SGLN Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SGLN and SPY.

Calendar-year return history is still loading or unavailable.
SurgLine International, Inc. logo

Company Overview

SurgLine International, Inc.

Other OTC

Surgline International, Inc. sources and sells medical and surgical products. It offers a range of surgical instruments, including scissors, forceps, basket punches, reamers, and pulse lavages. The company also provides surgical sets, such as hand and foot, and hips and small fragments; spine products consisting of ALIF systems, anterior cervical plates, PLIF systems, TLIF systems, cervical PEEK IBFDs, and pedicle screw systems; drill system and power tools comprising cordless and pneumatic drills, chucks, sleeves, saws, hoes, charges, and batteries. In addition, it offers emergency removal devices for broken screws and implant removal; a range of endoscopes; surgical burs and blades; and medical, surgical, and dental disposables. The company sells its products under the Surg brand. It serves acute care hospitals, ambulatory surgery centers, physicians, dentists, urgent care centers, and insurers, as well as others. The company was formerly known as China Nuvo Solar Energy, Inc. and changed its name to Surgline International, Inc. in October 2011. Surgline International, Inc. is based in Newport Beach, California.

Leadership
Thomas G. Toland
IPO Date
Sep 2, 2011
Street Address
319 Clematis Street
Mailing
West Palm Beach
Region
West Palm Beach, US
Reporting Currency
USD
Investor Line
+1 407 339 6351
Last Updated
May 4, 2026
ISIN: US8688481022CUSIP: 868848102
Reports in USD

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
5.0
Price/Book
โ€”

Growth

Revenue
0.0%
EPS
+95.0%
Free Cash Flow
-123.8%

Profitability

Gross Margin
34.4%
Operating Margin
-1832.4%
Net Margin
-2408.9%
ROE
171.6%
ROIC
176.9%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
0.06

Earnings Reports

No earnings data available

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.